CDSCO permits manufacturers of industrial oxygen to manufacture oxygen for medical use during COVID-19

Apr 17, 2020 | by Avantis RegTech Legal Research Team


Industry Specific Compliance

The Central Drugs Standard Control Organisation (CDSCO) on April 07, 2020, has decided to grant permission to manufacturers of industrial oxygen to manufacture oxygen for medical use in the situation of COVID-19 pandemic. The All India Industrial Gases Manufacturer’s Association (AIIGMA) proposes to allow manufacturers of industrial oxygen to manufacture oxygen as it is an essential part of clinical management of COVID-19 patient.

Thus, it is decided that premises which are having facility to manufacture industrial oxygen should be granted manufacturing license to manufacture oxygen within 24 hours of receiving the application, fees. etc. as per the Drugs and Cosmetics Act, 1940 and undertaking in writing to manufacture the medical oxygen with standards prescribed in Indian Pharmacopeia and labelling requirement.

[Notice No. DCGI/Misc/2020(96)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.